Transmissible spongiform encephalopathies (TSEs) are lethal, infectious disorders of the mammalian nervous system. A TSE hallmark is the conversion of the cellular protein PrP C to disease-associated PrP Sc (named for scrapie, the first known TSE). PrP C is protease-sensitive, monomeric, detergent soluble, and primarily ␣-helical; PrP Sc is protease-resistant, polymerized, detergent insoluble, and rich in ␤-sheet. The ''protein-only'' hypothesis posits that PrP Sc is the infectious TSE agent that directly converts host-encoded PrP C to fresh PrP Sc , harming neurons and creating new agents of infection. To gain insight on the conformational transitions of PrP, we tested the ability of several protein chaperones, which supervise the conformational transitions of proteins in diverse ways, to affect conversion of PrP C to its protease-resistant state. None affected conversion in the absence of pre-existing PrP Sc . In its presence, only two, GroEL and Hsp104 (heat shock protein 104), significantly affected conversion. Both promoted it, but the reaction characteristics of conversions with the two chaperones were distinct. In contrast, chemical chaperones inhibited conversion. Our findings provide new mechanistic insights into nature of PrP conversions, and provide a new set of tools for studying the process underlying TSE pathogenesis.
The family of transmissible spongiform encephalopathies (TSEs) include scrapie in sheep, bovine spongiform encephalopathy or ''mad cow disease'' in cattle, and several rare human neuropathies: Creutzfeld-Jacob disease, fatal familial insomnia, Gertsmann-Straussler-Scheinker syndrome, and kuru (1, 2) . A central event in TSE pathogenesis is the accumulation in the nervous system of an abnormally folded version (PrP Sc ) of a normal cellular protein, PrP C . Griffith (3) first proposed a ''protein-only'' model to explain the unconventional behavior of the infectious TSE agent. Indeed, the ''prion'', a term by which the agent is popularly known today, appears to be almost entirely proteinaceous: consisting primarily of PrP Sc (1, 2) .
Several lines of evidence show that PrP C is conformationally distinct from PrP Sc , although both molecules derive from the same primary sequence and have no detectable posttranslational differences (1, 2, (4) (5) (6) . The conversion of PrP C to PrP Sc appears to involve direct interactions of PrP C with pre-existing PrP Sc (1, 2) . However, the exact mechanism underlying conversion is not known. Genetic and inhibitor studies have suggested that other cellular factors may influence TSE pathogenesis or serve as regulators of disease (7) (8) (9) (10) (11) (12) . None have been conclusively identified; however, cellular osmolytes (sometimes called chemical chaperones; ref. 13 ) and protein chaperones have been frequently speculated to be among them (7, (10) (11) (12) . The goal of this study was to assess whether or not molecular chaperones, whose known functions are to alter the conformational states of proteins (14) (15) (16) (17, 18) . In this altered state, PrP is aggregated and a specific portion of the molecule is highly resistant to proteolysis. This simple in vitro conversion reaction faithfully recapitulates several salient TSE features. First, like experimental TSEs, in vitro conversion of PrP C to its protease-resistant form requires pre-existing PrP Sc (17) (18) (19) (20) (21) (22) . Second, strain-specific PrP Sc protease digestion properties, specifically those associated with two mink TSE strains-hyper and drowsy-were precisely propagated from PrP Sc to radiolabeled PrP C in this assay (19) . Third, the known in vivo barriers to transmitting TSEs between different species were reflected well in the efficiencies of in vitro conversion (20, 21) . Last, this cell-free assay modeled accurately another in vivo TSE barrier, based on genetic polymorphisms in PrP, which render sheep either highly susceptible, moderately susceptible, or resistant to scrapie (22) . Together, these studies provide substantial evidence that in vitro converted, protease-resistant PrP is either authentic PrP Sc or has a very similar conformation. However, because neither the putative infectious nature of pure PrP Sc protein nor that of the in vitro converted PrP has been demonstrated, we refer to the in vitro converted material operationally as protease-resistant PrP (PrP-res).
Here, we provide the first evidence that molecular chaperones can regulate conformational transitions in PrP. Two protein chaperones, GroEL and Hsp104 (heat shock protein 104), promoted in vitro conversion; in contrast, the chemical chaperones, sucrose, trehalose, and dimethyl sulfoxide (DMSO) inhibited it. Importantly, our results with chaperones demonstrate that in vitro converted PrP-res is a bona fide conformationally altered PrP molecule. Chaperones provide new understanding of the nature of PrP intermediates involved in PrP conversion and provide evidence that the conversion process has two steps. We propose that, if chaperone-like molecules supervise PrP Sc formation in TSEs in vivo, such molecules will represent important clinical targets to combat this dreaded disease.
as described (23) (24) (25) and were generous gifts of J. R. Glover and Y. Kimura (University of Chicago, IL). Bacterial GroES and GroEL (WT and mutant) were kindly provided by A. L. Horwich (Yale University, New Haven, CT). Hsp26 was a generous gift of T. Suzuki and E. Vierling (University of Arizona, Tucson), and yeast Hsp90 was kindly provided by J. Buchner (Universität Regensburg, Regensburg, Germany).
Chaperone Folding Assays. Hsp104 promoted the refolding of kinetically trapped, denatured luciferase, but only when Hsp40, Hsp70, and ATP were also present (J. R. Glover and S.L., unpublished data). The function of other chaperones were assessed by using previously published procedures. GroEL and GroES activities were measured by the refolding of denatured rhodanese (26) ; Hsp90 suppressed the aggregation of ␤-galactosidase (27) ; and Hsp26 activity was measured by the suppression of aggregation of malate dehydrogenase (28) .
PrP Purification. PrP Sc was purified from hamsters infected with 263K strain of scrapie as described (17) . Hamster Cell-Free PrP Conversion. Unless otherwise stated, all reactions were performed by using the same modification of a published procedure (18) . 
RESULTS

Chaperones Alone Do Not Convert PrP
C to PrP-res. We first examined the ability of major cellular chaperones GroES (Hsp10), Hsp26, Hsp40, GroEL (Hsp60), Hsp70, Hsp90, and Hsp104, to promote [ 35 S]PrP C conversion in the absence of PrP Sc . These chaperones were chosen because they employ different mechanisms to affect the conformation and physical state of other proteins (14) (15) (16) . In separate experiments, these same chaperone preparations functioned appropriately in a variety of protein folding assays (data not shown). Yet, over a broad range of concentrations, alone and in various combinations, with (Fig. 1A) or without ATP (data not shown), none of these chaperones promoted the conversion of PrP C to PrP-res in the absence of PrP Sc . This observation strongly underscores the importance of pre-existing PrP Sc in the conversion of PrP C .
GroEL 1D) and no converting ability, respectively (17, 18) . We first asked whether chaperones influenced conversion with PrP-res that was not subjected to partial denaturation. Several chaperones produced reproducible, but very small increases in conversion ( Fig. 1 B and D) . One, however, facilitated conversion at a high level ( Fig. 1 A and B) . With GroEL, typically 25-30%, and occasionally 50-100%, of converted
Notably GroEL not only reduced by 10-fold the quantity of PrP Sc required for detectable conversion, but also increased by more than 10-fold the maximal levels of conversion attained, compared with reactions nucleated with the same preparation of untreated PrP Sc , but not with GroEL (Fig. 1D) . These effects of GroEL were dose-dependent (Fig. 1C) .
GroEL Effects Require ATP, But Not GroES. GroELpromoted protein folding usually, but not always, requires the cochaperone GroES and ATP (14, 15) . PrP conversion was not observed in the absence of ATP (Fig. 1E) . Moreover, two point mutants of GroEL, which block release of substrate (D87K and 337͞349; ref. 29) , strongly reduced conversion (Fig.  1E, and data not shown) . Surprisingly, however, the stimulating effects of GroEL on [ 35 S]PrP C conversion were consistently eliminated by GroES (Fig. 1D) . This inhibition was caused by an effect of GroES on GroEL, rather than on PrP, because GroES did not inhibit the denaturant-promoted conversion of [ 35 S]PrP C that occurs in the absence of GroEL (data not shown).
Posttranslational PrP Modifications Modestly Affect Chaperone-Promoted Conversions. We used a PrP mutant that lacks the glycosylphosphatidylinositol (GPI) anchor (PrP GPI-; refs. 17 and 18) and accumulates in mono-and unglycosylated form (Fig. 1F Right) to determine whether these natural modifications affect chaperone-mediated conversion. Again, of the various chaperones tested, GroEL was the only one that efficiently stimulated conversion in the presence of untreated PrP Sc (Fig. 1F, and data not shown) . And once again, GroELpromoted effects were ablated in the absence of ATP (data not shown) and inhibited by GroES (Fig. 1F) . With this form of PrP, however, conversion was more efficient (typically 30-40%). Moreover, conversion was also achieved with a combination of Hsp104, Hsp70, and Hsp40, albeit less consistently and less strongly than with GroEL (Fig. 1F) . Results similar to those obtained with PrP GPI-were also obtained with unglycosylated [ 35 (Fig. 2 A and B) . In reactions driven with untreated PrP Sc and GroEL, protease resistance was acquired at a pace similar to that observed in reactions nucleated with partially denatured PrP Sc in the absence of GroEL (Fig. 2 A) . Moreover, in both sets of reactions, protease-resistant radioactivity was found only in pelletable material (Fig. 2C) . Surprisingly, however, when the rate at which [ 35 S]PrP became insoluble was examined, the chaperone-driven reaction showed very different kinetics than those driven by partially denatured PrP Sc . No pelletable radioactivity was detected at two hours in reactions driven by partially denatured PrP Sc ( Fig.   2 A and B) . In striking contrast, in chaperone-driven reactions, the conversion of PrP to a pelletable form was virtually complete in 2 hr. This conversion occurred long before [
35 S]PrP converted to its characteristic protease-resistant form ( Fig. 2 A and B) . This pelleting of [ 35 (Fig. 2B) . In Reactions Nucleated with Partially Denatured PrP Sc , Hsp104 also Promotes Conversion. Although we did not detect a substantial activity for other chaperones in promoting conversion with untreated PrP Sc , another chaperone was effective in reactions seeded with partially denatured PrP Sc . For these reactions, a milder denaturant, urea, was used because some chaperones are sensitive to inhibition by Gdn⅐HCl (ref. 31 ; J. R. Glover and S.L., unpublished observations with Hsp104). Moreover, the lower basal rate of conversion obtained with urea (Fig. 3A, buffer) allowed us to test the ability of other chaperones to either inhibit or stimulate conversion. None inhibited (Fig. 3A) . Several stimulated, but only to a small degree (Fig. 3A) . Strikingly, under these conditions, in addition to GroEL, Hsp104 strongly stimulated conversion (Fig.  3A) . With Hsp104, typically 20-30%, occasionally more than 50% of total [ 35 S]PrP C converted. The stimulatory effects of Hsp104 required partial denaturation of PrP Sc , with pretreatments in 3-4 M urea being optimal (Fig. 3B) .
Folded State of PrP Sc Governs Properties of ChaperonePromoted Conversion. Although some Hsp104 functions require ATP (16, 32) , in these reactions nucleotide was somewhat stimulatory but was not required (Fig. 3C) (Fig. 3C, and data not shown) .
Remarkably, the use of partially denatured PrP Sc changed the character of conversions promoted by GroEL as well. These conversions lost ATP-dependence (Fig. 3D) . Moreover, they became refractory to GroES inhibition (Fig. 3A) . Thus, chaperone-mediated conversions are mechanistically distinct in reactions nucleated with partially denatured PrP Sc , and those nucleated by untreated PrP Sc .
Chemical Chaperones Inhibit Conversion. We also tested the effects of several small organic molecules (or chemical chaperones) known to affect protein folding: sucrose, glycerol, trehalose, DMSO, and the cyclodextrin compounds (8, 13, 34) .
None of the compounds we tested affected [ 35 S]PrP C conversions in reactions without PrP Sc , nor in reactions seeded with untreated PrP Sc (data not shown). In reactions seeded with partially denatured PrP Sc , DMSO had a complex dosedependent effect, intermediate levels (1-3%) stimulated conversion 2-to 3-fold and higher levels (up to 30%) virtually eliminated conversion (Fig. 4) . Glycerol (Fig. 4) and cyclodextrin compounds (␣-, ␤-, ␥-forms; data not shown) had no effect. Sucrose and trehalose inhibited conversion. This inhibition was observed only at high concentrations, but is physiologically relevant because these osmolytes are known to accumulate to such levels in vivo under stressful conditions (34) .
DISCUSSION
Recently, protein chaperones and small organic molecules have figured prominently among cellular factors speculated to influence conversion of PrP C to PrP Sc (7, 8, 11, 12) . In scrapie-infected cells, some of the same organic molecules we tested have been shown to reduce the rate of PrP Sc formation (8) . We provide the first evidence that protein chaperones and small organic molecules can directly affect conformational transitions of PrP. Our findings, along with the accompanying study (35) , also provide the first direct demonstration that chaperone Hsp104 can alter the conformation state of another protein.
In studying the conversion of PrP (40) . Of the chaperones we tested, only GroEL and Hsp104 affected conversion. Our results indicate that such chaperone interactions in vivo, if they occur, are likely to be highly specific. Clearly, the elucidation of PrP chaperone interactions in vivo are of great import as they provide potential targets for therapeutic intervention.
Of more immediate application, chaperones provide new tools for probing the basic nature of PrP conversion. Here, they have yielded several novel insights. First, chaperones provide a strong demonstration of the importance of PrP Sc in creating a template for PrP C conversion. The chaperones we tested interact with different folding intermediates, bind them in different ways, and promote conformational changes by distinct mechanisms (14) (15) (16) ). Yet none could promote the conversion of acid-treated PrP C to PrP-res in the absence of PrP Sc . Second, the specific effects of different chaperones provide information about the nature of PrP intermediates on the pathway of PrP Sc formation. On the one hand, the ability of osmolytes to inhibit PrP conversion correlates with their known ability to stabilize proteins in the folded state (13, 34) . On the other, the unique ability of GroEL and Hsp104, among protein chaperones, to promote refolding of PrP C to PrP-res correlates well with their ability to speed the refolding of kinetically trapped intermediates (refs. 14-16; J. R. Glover and S.L., unpublished observations with Hsp104).
With (Fig. 5) .
Fourth, our findings provide a ''proof of principle'' that the acquisition of protease resistance in PrP-res results from an authentic conformational change in PrP. Despite the high degree of specificity (17, (19) (20) (21) (22) 30) , the in vitro conversion assay has been subject to the criticism that the proteaseresistance of [ 35 S]PrP results from nonspecific aggregation or association with PrP Sc . That chaperones, which alter the conformation states of other proteins, promote the conversion of PrP C to a pelletable form, and a second step must ensue to generate the specific protease-resistant form of PrP, further establishes that PrP-res is a conformationally altered molecule and not simply a nonspecific aggregate.
Fifth, the ability of chaperones to enhance at least one step in the conversion process may provide an avenue for generating sufficient quantities of PrP Sc in vitro to test the ''proteinonly'' hypothesis.
Finally, our observations provide a unifying biochemical connection between mammalian TSEs (the so-called prion diseases) and [PSIϩ] , a genetic element in yeast (sometimes called a ''yeast prion;'' ref. 41) . The proposed ''mammalian prion'' determinant PrP Sc , and the ''yeast prion'' determinant Sup35, are functionally unrelated and share no sequence identity. Also, [PSIϩ] produces a heritable change in metabolism rather than a lethal infection. However, both mammalian and yeast prions apparently share a common mode of transmission based on self-propagating changes in protein confor- mation (42) (43) (44) . Among yeast chaperones, the striking specificity of Hsp104 for PrP conversions, and its known in vivo specificity in regulating [PSIϩ] (41) (42) (43) (44) suggest that conformations of PrP and Sup35 share an underlying biochemical similarity that allows for recognition by particular chaperones and prion-like conformational transitions. In added support of this notion, the accompanying study (35) provides evidence for specific interactions of Hsp104 with PrP and Sup35 proteins with circular dichroism and ATP hydrolysis measurements.
